Analysis of the effect of memantine in reducing the worsening of clinical symptoms in patients with moderate to severe Alzheimer's disease
Wilkinson, D. and Andersen, H.F. (2007) Analysis of the effect of memantine in reducing the worsening of clinical symptoms in patients with moderate to severe Alzheimer's disease. Dementia and Geriatric Cognitive Disorders, 24, (2), 138-145. (doi:10.1159/000105162).
Full text not available from this repository.
Background: Alzheimer's disease ( AD) is a progressive neurodegenerative disorder and delaying disease worsening is a relevant treatment outcome. Methods: Data from 6 randomized, double-blind, placebo-controlled, 6-month studies were pooled and a subgroup of patients ( 867 on placebo, 959 on memantine) with moderate to severe AD ( MiniMental State Examination < 20) was analyzed. 'Any clinical worsening' was defined as a decline on the Alzheimer's Disease Assessment Scale - Cognitive Subscale (ADAS-cog) or the Severe Impairment Battery ( SIB) and on the Clinician's Interview-Based Impression of Change Plus Caregiver In put (CIBIC-plus) and the Alzheimer's Disease Cooperative Study - Activities of Daily Living Inventory (ADCS-ADL), and 'marked clinical worsening' as 6 4 points decline on the ADAS-cog or 6 5 points on the SIB and decline on the CIBIC-plus and the ADCS-ADL. Results: More placebo-treated than memantine-treated patients showed any clinical worsening ( 28 vs. 18%; p < 0.001), and 21% placebo-treated patients compared to 11% memantine-treated patients had marked clinical worsening ( p < 0.001). Conclusion: In this population of moderate and severe AD patients, treatment with memantine was associated with reducing worsening of clinical symptoms in AD during the 6-month study period. Copyright (c) 2007 S. Karger AG, Basel
|Keywords:||inventory, therapy, population, disorder, memory, clinical worsening, double-blind, alzheimer's disease, moderate, controlled-trial, placebo, treatment,cognitive, demented patients, severe impairment battery, alzheimer's disease, impairment, disease, cibic-plus, symptoms, validity, adcs-adl, memantine,global,ad, scale,function|
B Philosophy. Psychology. Religion > BF Psychology
|Divisions:||University Structure - Pre August 2011 > School of Medicine
|Date Deposited:||09 Sep 2008|
|Last Modified:||01 Jun 2011 12:21|
|Contributors:||Wilkinson, D. (Author)
Andersen, H.F. (Author)
|RDF:||RDF+N-Triples, RDF+N3, RDF+XML, Browse.|
Actions (login required)